Renergen Ltd (RLT) - Total Liabilities

Latest as of August 2025: AU$1.70 Billion AUD ≈ $1.20 Billion USD

Based on the latest financial reports, Renergen Ltd (RLT) has total liabilities worth AU$1.70 Billion AUD (≈ $1.20 Billion USD) as of August 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Renergen Ltd to evaluate the company's liquid asset resilience ratio.

Renergen Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Renergen Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see RLT current and non-current assets.

Renergen Ltd Competitors by Total Liabilities

The table below lists competitors of Renergen Ltd ranked by their total liabilities.

Company Country Total Liabilities
Naturel Yenilenebilir Enerji Ticare
IS:NATEN
Turkey TL8.02 Billion
ShareHope Medicine Co Ltd
TWO:8403
Taiwan NT$2.78 Billion
Selectquote Inc
NYSE:SLQT
USA $671.22 Million
PJBumi Bhd
KLSE:7163
Malaysia RM45.39 Million
KPS Corporation
KQ:256940
Korea ₩123.69 Billion
AVE S.A.
AT:AVE
Greece €33.44 Million
R. Stahl AG NA O.N.
F:RSL2
Germany €206.67 Million
Micropolis Holding Company
NYSE:MCRP
USA $40.58 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Renergen Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Renergen Ltd (RLT) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.18 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.09 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.94 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.64 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Renergen Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Renergen Ltd (2013–2025)

The table below shows the annual total liabilities of Renergen Ltd from 2013 to 2025.

Year Total Liabilities Change
2025-02-28 AU$1.23 Billion
≈ $873.53 Million
-11.06%
2024-02-29 AU$1.39 Billion
≈ $982.12 Million
+30.86%
2023-02-28 AU$1.06 Billion
≈ $750.50 Million
+20.75%
2022-02-28 AU$878.38 Million
≈ $621.51 Million
+53.04%
2021-02-28 AU$573.95 Million
≈ $406.11 Million
+51.33%
2020-02-29 AU$379.26 Million
≈ $268.35 Million
+523.00%
2019-02-28 AU$60.88 Million
≈ $43.07 Million
+33.53%
2018-02-28 AU$45.59 Million
≈ $32.26 Million
+28.00%
2017-02-28 AU$35.62 Million
≈ $25.20 Million
+18.32%
2016-02-29 AU$30.10 Million
≈ $21.30 Million
-57.93%
2015-02-28 AU$71.55 Million
≈ $50.63 Million
+4.86%
2014-02-28 AU$68.23 Million
≈ $48.28 Million
+9.87%
2013-02-28 AU$62.11 Million
≈ $43.94 Million
--

About Renergen Ltd

AU:RLT Australia Oil & Gas E&P
Market Cap
$82.34 Million
AU$116.38 Million AUD
Market Cap Rank
#20043 Global
#661 in Australia
Share Price
AU$0.75
Change (1 day)
+0.00%
52-Week Range
AU$0.71 - AU$1.45
All Time High
AU$3.99
About

Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperatur… Read more